AI is making headlines as it reshapes American healthcare diagnostics in 2026. Faced with a staffing crunch and a population that’s getting older fast, health systems are investing in smart, scalable technology to keep pace. It’s paying off—hospitals nationwide are accelerating adoption of AI-driven tools, and the US market for AI-enabled diagnostics is projected to reach several billion dollars by the early 2030s. The AI health shift is no longer theoretical. It is actively reshaping clinical workflows.
Major hospitals are prioritizing opportunistic screening, using computer vision and advanced AI systems to catch incidental findings that clinicians might miss due to fatigue. Beyond improving clinical accuracy, these tools help address the significant administrative burden in US healthcare by automating reporting and applying natural language processing. Regulatory pathways are evolving, with the FDA expanding frameworks for AI-based devices and CMS introducing select reimbursement codes, such as CPT 92229, making AI increasingly viable in practice.
Our top picks spotlight innovators leading this space, chosen for clinical impact, market strength, and technology-driven innovation. Adoption is accelerating across major health systems, with many hospitals integrating AI into imaging and workflow tools. The industry is moving toward a more balanced approach to automation, clinical equity, and sustainable growth.
1 | Siemens Healthineers AG
Chief Executive Officer: Dr Bernd Montag
Headquarters: Munich and Erlangen, Germany (U.S. Operations: Chicago, IL)
Areas of Operation: Worldwide (Serving all major U.S. health systems)
Industries: Medical Technology, Laboratory Diagnostics, Digital Health, AI
Siemens Healthineers, led by CEO Dr. Bernd Montag and headquartered in Germany with US operations in Chicago, serves major US health systems and works globally. It leads in medical technology, laboratory diagnostics, digital health, and AI. Siemens Healthineers has evolved from a hardware-focused manufacturer to a digital innovation leader. Its AI platforms make multi-modal reading and structured reporting possible, so radiologists can spend more time on complex cases. With more than 74,000 professionals worldwide, Siemens Healthineers delivers clinically validated AI solutions across the care continuum.
2 | GE HealthCare Technologies Inc.
Chief Executive Officer: Peter J. Arduini
Headquarters: Chicago, Illinois, USA
Areas of Operation: Global (Serving providers, researchers, and health systems)
Industries: Medical Technology, Pharmaceutical Diagnostics, Digital Solutions, AI
GE HealthCare helps hospitals run more efficiently and deliver precise therapies. After spinning off in early 2023, it sharpened its digital strategy to focus on medtech and data science. GE HealthCare provides advanced imaging, ultrasound, and patient care solutions powered by real-time clinical data. By offering integrated solutions, GE HealthCare aims to improve patient outcomes everywhere. Its leadership is focused on driving better clinical outcomes through technology and data-driven insights.
3 | Tempus
Chief Executive Officer: Eric Lefkofsky
Headquarters: Chicago, Illinois, USA
Areas of Operation: United States (Broad network of academic and community oncology centres)
Industries: Technology (AI/Data Science), Life Sciences, Healthcare, Oncology
Tempus, launched in 2015 and led by CEO Eric Lefkofsky, is headquartered in Chicago. With a broad network of academic and community oncology centers across the US, Tempus operates in AI, life sciences, healthcare, and oncology. It uses artificial intelligence to turn healthcare data into better patient outcomes, drawing on a large data library to personalize care in oncology and other complex conditions. Its technology stack spans genomic sequencing, molecular profiling, and AI-powered treatment matching—plus support for drug development via high-throughput biological modeling.
4 | PathAI
Chief Executive Officer: Andrew H. Beck, MD, PhD
Headquarters: Boston, Massachusetts, USA
Areas of Operation: Global (Clinical labs, biopharma companies, academic centers)
Industries: Digital Pathology, AI, Biotechnology, Clinical Diagnostics
PathAI, founded in 2016 and led by CEO Andrew H. Beck, MD, PhD, is based in Boston. It works with clinical labs, biopharma firms, and academic centers around the world, specializing in digital pathology, AI, biotech, and clinical diagnostics. PathAI uses advanced technology to reduce diagnostic errors, blending computational expertise with medical knowledge for robust pathology solutions. Its platform improves diagnosis, matches patients with effective treatments, and supports drug development. PathAI integrates AI into workflows and has received FDA Breakthrough Device Designation for select applications, including PathAssist Derm.
5 | Paige AI
Chief Executive Officer: Leo Grady, PhD
Headquarters: New York, New York, USA
Areas of Operation: Global (Clinical labs, cancer centers, biopharma)
Industries: Digital Pathology, AI, Oncology Diagnostics
Paige AI, founded in 2017 and led by CEO Leo Grady, PhD, is headquartered in New York. The company specializes in AI-powered digital pathology, supporting clinical labs, cancer centers, and biopharma organizations worldwide. Paige develops diagnostic algorithms trained on large-scale clinical datasets to assist pathologists in detecting and characterizing cancer with greater accuracy. Its platform integrates into existing workflows, enabling faster and more consistent diagnoses while supporting research and drug development. With growing regulatory momentum and clinical adoption, Paige AI is emerging as a key player in next-generation cancer diagnostics.
6 | Aidoc
Chief Executive Officer: Elad Walach
Headquarters: New York, NY, USA and Tel Aviv, Israel
Areas of Operation: Global (Health systems, hospitals, emergency departments)
Industries: Medical Imaging, AI, MedTech, Radiology
Aidoc, founded in 2016 and led by CEO Elad Walach, has headquarters in New York and Tel Aviv. Serving health systems, hospitals, and emergency departments worldwide, Aidoc specializes in medical imaging, AI, medtech, and radiology. Its AI Operating System, aiOS, coordinates image data and algorithms to improve healthcare quality and efficiency. The CARE foundation model is built for clinical-grade healthcare, prioritizing urgent studies in emergency radiology. Under Elad’s leadership, Aidoc has seen widespread adoption in emergency radiology workflows.
7 | Viz.ai
Chief Executive Officer: Chris Mansi, MD
Headquarters: San Francisco, California, US
Areas of Operation: United States and International (Care coordination networks)
Industries: AI, Digital Health, Care Coordination, Neuroscience
Viz.ai, founded in 2016 and led by CEO Chris Mansi, MD, is based in San Francisco. It builds care coordination networks in AI, digital health, and neuroscience across the US and internationally. Viz.ai uses artificial intelligence to improve access to timely treatments with AI-powered care coordination for cardiovascular and neurovascular conditions. Its system instantly notifies specialists when patients need critical care, streamlining workflows across hundreds of hospitals.
8 | Butterfly Network, Inc.
Chief Executive Officer: Joseph M. DeVivo
Headquarters: Burlington, Massachusetts, USA
Areas of Operation: Global (Healthcare providers, community health, remote care)
Industries: Digital Health, Medical Devices (Ultrasound), AI
Butterfly Network brings accessible, affordable medical imaging to healthcare. Founded by Dr. Jonathan Rothberg, the company spent years perfecting its silicon-chip ultrasound technology. Under Joe DeVivo’s leadership, Butterfly is expanding globally. Its software connects with major EHRs, letting diagnostic data flow smoothly into patient records. By making complex procedures simpler through AI-guided imaging, Butterfly Network enables healthcare professionals to deliver life-saving assessments at the bedside.
9 | Digital Diagnostics
Chief Executive Officer: Luke Miller
Headquarters: Coralville, Iowa, USA
Areas of Operation: Global (Primary focus on U.S. primary care and specialized clinics)
Industries: Healthcare AI, MedTech, Autonomous AI Diagnostics
Digital Diagnostics, founded by Michael Abramoff, MD, PhD, and led by CEO Luke Miller, is headquartered in Coralville, Iowa. It operates worldwide, focusing on US primary care and specialty clinics. Digital Diagnostics stands out in healthcare AI, medtech, and autonomous AI diagnostics. Its LumineticsCore platform delivers point-of-care diagnosis for diabetic retinopathy. By partnering with regulators and providers, Digital Diagnostics has achieved industry firsts—including an autonomous AI CPT code—helping improve access to affordable, high-quality care.
10 | Cleerly, Inc.
Chief Executive Officer: James K. Min, MD
Headquarters: Denver, Colorado, USA
Areas of Operation: United States (Health systems, cardiology practices, research labs)
Industries: Healthcare, AI, Cardiology, Diagnostic Imaging
Dr. James Min, a world-renowned cardiologist and former professor at Weill Cornell Medical College, founded Cleerly. It bases its products on more than 15 years of clinical trial research and hundreds of peer-reviewed studies. Cleerly’s AI-driven approach introduces a new staging system for coronary artery disease, helping clinicians measure plaque burden with precision. By offering a clearer view of heart health, Cleerly supports early intervention and helps reduce unnecessary invasive procedures. Leading health systems are increasingly adopting its technology in cardiovascular care.
Clinical specialization is now at the heart of American healthcare. AI has shifted from a general-purpose tool to a precision instrument. From portable ultrasound to large-scale clinical data platforms, technology is becoming central to modern medicine. This transition marks a move from pilot programs to broader clinical integration. These advancements are enabling faster, more personalized care while strengthening the overall US healthcare ecosystem.
